Professional Documents
Culture Documents
History
Long time use of non-standardized, ambiguous terminology. English language terminologies with
Greek or Latin roots are poorly defined and create ambiguity in meaning and usage.
In 2005, interest group of 35 experts did historical review, and recommendations made for
uniform terminology published. A Delphi panel created to analyze recommendations. They
recommended discarding the confusing terminology, and replace with simple descriptive terms
that could be understood by patients and translated into most languages.
In 2006, FIGO identified as the appropriate body to provide supervision and international
credibility to the ongoing evaluation of new terminology. Formed the FIGO Menstrual Disorders
Group. In 2009, FIGO World Congress of Gynecology and Obstetrics (17 countries from 6
continents) accepted the new terminology. The PALM-COEIN Classification System created.
Supported by ACOG (Practice Bulletin No. 128, July 2012)
Disturbances in Frequency
Infrequent Menstrual Bleeding: One or two episodes in a 90-day period.
Frequent Menstrual Bleeding: More than four episodes in a 90-day period.
Acute AUB
An episode of bleeding in a woman of reproductive age, who is not pregnant, of sufficient quantity to require
immediate intervention to prevent further blood loss.
Chronic AUB
Bleeding from the uterine corpus that is abnormal in duration, volume, and/or frequency and has been
present for the majority of the last 6 months.
Patterns of Bleeding
The “shape” of the volume of the bleeding pattern over the days of one menstrual period. It is usually
recognized that about 90% of the total menstrual flow is lost within the first 3 days of the cycle, with day
1 or 2 the heaviest. In women with AUB this pattern is variable.
Polyps (AUB-P)
Abnormal vaginal bleeding is the most common presenting symptom. Accounts for all causes of abnormal vaginal
bleeding in 39% of pre-menopausal and 21-28% in post-menopausal women. Polyps are categorized as either
present or absent. Diagnosed by TVUS, saline infusion sonography, and hysteroscopy.
Adenomyosis (AUB-A)
70% of women with adenomyosis have symptoms of AUB. 30% have dysmenorrhea. 19% have both. Diagnosed by
ultrasound or MRI.
Malignancy (AUB-M)
AUB is the primary symptom of endometrial neoplasia. 70% of PMB with AUB have benign findings, 15% have
hyperplasia, and 15% have endometrial cancer. Approximately 50% of women diagnosed with endometrial
hyperplasia have concurrent carcinoma. AUB-M includes both premalignant and malignant lesions.
Coagulopathies (AUB-C)
13% of women with HMB have a disorder of hemostasis that may be overlooked during the differential diagnosis.
Iatrogenic (AUB-I)
Causes include IUD, exogenous gonadal steroids and other systemic agents that affect blood coagulation or ovulation.
Bleeding from anticoagulation therapy is listed under AUB-C rather than AUB-I.
Notation of AUB
A patient may be found to have more than one potential entity contributing to symptoms of AUB. A notation approach
has been designed to enable categorization.
For example, if a patient is found to have endometrial hyperplasia and ovulation dysfunction with no other
abnormalities, she would be categorized as follows:
AUB P0 A0 L0 M1 – C0 O1 E0 I0 N0
May be abbreviated as: AUB – M;O
Diagnostic Evaluation of AUB
Medical History
Age of menarche and menopause
Menstrual bleeding patterns
Severity of bleeding (clots or flooding)
Pain (severity and treatment)
Medical conditions
Surgical history
Use of medications
Symptoms and signs of possible hemostatic disorder
Physical Exam
General physical
Pelvic Examination
External
Speculum with Pap test, if needed.
Bimanual
Laboratory Tests
Pregnancy test (blood or urine)
Complete blood count
TSH
Chlamydia trachomatis
Targeted screening for bleeding disorders (when indicated, based on history*):
PT, PTT, specific tests for von Willebrand disease, von Willebrand-ristocetin
cofactor activity, von Willebrand factor antigen, and factor VIII
626 Disorders of menstruation and other abnormal bleeding from female genital tract
626.0 Amenorrhea (primary) (secondary)
626.1 Scanty or Infrequent menstruation, Hypomenorrhea, Oligomenorrhea
626.2 Excessive or frequent menstruation, Heavy periods, Menorrhagia,
Menometrorrhagia, Polymeorrhea
626.4 Irregular menstrual cycle, Irregular bleeding, Irregular menstruation, Irregular
periods
626.5 Ovulation bleeding, Regular intermenstrual bleeding
626.6 Metrorrhagia, Bleeding unrelated to menstrual cycle, Irregular intermenstrual
bleeding
626.8 Dysfunctional or functional uterine hemorrhage
627.1 Postmenopausal bleeding
621.0 Polyp of corpus uteri, Endometrium, Uterus
617.0 Endometriosis of uterus, Adenomyosis
625.3 Dysmenorrhea, Painful menstruation
218.0 Submucous leiomyoma of uterus
218.1 Intramural leiomyoma of uterus
218.2 Subserous leiomyoma of uterus
218.9 Leiomyoma of uterus, unspecified
182.0 Malignant neoplasm of body of uterus, endometrium
621.30 Endometrial hyperplasia, unspecified
621.31 Simple endometrial hyperplasia without atypia
621.32 Complex endometrial hyperplasia without atypia
621.33 Endometrial hyperplasia with atypia
621.34 Benign endometrial hyperplasia
CPT Codes
Many of the suggestions for the new terminology might be included in the ICD-10 changes that
may be implemented in 2014.